KLK3 and prostate carcinoma: Fourth, granular prostate cancer characteristics aside from clinical T‐stage, documented PSA, and Gleason score, such as PSA kinetics or detailed histopathologic assessment (e.g., percent positive cores, perineural invasion, etc.), are not available in the NCDB.